BluePerspectives

FDA panel backs Eli Lilly’s Alzheimer’s drug

A federal advisory committee voted on Monday to recommend Eli Lilly’s drug that is being considered for its potential ability to slow down the progression of Alzheimer’s disease. The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee (PNCNS) met on Monday to discuss Eli Lilly donanemab. The committee’s voting member were…

 A federal advisory panel on Monday approved recommending Eli Lilly’s fresh drug because it could stop Alzheimer’s disease from progressing. The Food and Drug Administration’s ( FDA ) Peripheral and Central Nervous System Drugs Advisory Committee met Monday to discuss Eli Lilly’s donanemab. The committee’s voting members were … A federal advisory panel on Monday approved recommending Eli Lilly’s fresh drug because it could stop Alzheimer’s disease from progressing. The Food and Drug Administration’s ( FDA ) Peripheral and Central Nervous System Drugs Advisory Committee met Monday to discuss Eli Lilly’s donanemab. The committee’s voting members were … 

A federal advisory committee voted on Monday to recommend Eli Lilly’s drug that is being considered for its potential ability to slow down the progression of Alzheimer’s disease. The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee (PNCNS) met on Monday to discuss Eli Lilly donanemab. The committee’s voting member were…

  

You May Also Like

Government Corruption

Updated 5/17/19 9:52am Jack Crane | Opinion  James Baker, Former-FBI General Counsel has joined Russian hoax media collaborator Michael Isikoff on his podcast, yesterday....

Crime

I do not even know where to begin with this one.  Just when you think you have seen the worst that humanity has to...

US Politics

“CLINTON LIKES THEM (GIRLS) YOUNG” (It’s about what I was expecting)   YOU CAN DOWNLOAD THE LIST FOR YOURSELF HERE   By Charles Roberson...

US Politics

The Cheney Family has shown themselves to be one of the most evil houses in the United States. Be it her father Dick (aptly...

Exit mobile version